Fresenius Kabi (Schweiz) AG

Fresenius Kabi at a glance

Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, we focus on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, we offer products for collection and processing of blood and cell components.


Fresenius Kabi (Schweiz) AG

Am Mattenhof 4

6010 Kriens

Phone +41 41 552 70 00